Viking Therapeutics, Inc. (VKTX)

Last Closing Price: 25.84 (2026-11-19)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Viking Therapeutics, Inc. (VKTX) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-183.19M
Cost of Goods Sold
--
--
$187.11M
$-187.11M
$3.93M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-183.19M
$-187.11M
$-187.75M
118.05M
118.05M
$-1.55
$-1.55
Balance Sheet Financials
$973.00M
--
$4.17M
$977.17M
$133.90M
$250.66M
$254.67M
$388.57M
$588.60M
$588.60M
$588.60M
127.52M
Cash Flow Statement Financials
$-377.34M
$256.14M
$633.21M
$165.81M
$677.81M
$512.00M
$39.36M
--
--
Fundamental Metrics & Ratios
7.27
--
--
0.30
0.43
--
--
--
--
--
--
$-377.34M
--
--
--
--
--
--
--
-31.12%
-31.12%
-18.75%
-21.83%
$4.62
$-3.20
$-3.20